Featured Research

from universities, journals, and other organizations

Clot-Buster Keeps Heart Devices Humming

Date:
September 17, 2002
Source:
American Heart Association
Summary:
Injecting a clot-buster unclogged a mechanical heart pump, restoring blood flow, according to a study in Circulation: Journal of the American Heart Association.

DALLAS, Sept. 17 – Injecting a clot-buster unclogged a mechanical heart pump, restoring blood flow, according to a study in today's special surgery issue of Circulation: Journal of the American Heart Association.

"This is such a simple solution to a very serious problem for heart failure patients who receive left ventricular assist devices (LVADs)," says lead author Markus Rothenburger, M.D., a resident in cardiovascular surgery at University Hospital in Muenster, Germany.

An LVAD is a mechanical pump-type device surgically implanted to maintain the pumping ability of a heart that can't effectively work on its own. Clot-busting drugs, also known as thrombolytic therapy, dissolve blood clots that impair blood flow. Most LVADs are based on a pulsatile blood flow. It has been reported that up to 47 percent of all patients with a pulsatile LVAD develop clotting complications, according to the report.

The recently introduced MicroMed DeBakey VAD, the device used in this study, differs from other LVADs in that it generates a continuous blood flow rather than a pulsing one. Their advantage over similar devices is smaller size, which seems to have reduced the incidence of thromboembolism and infections. It is also quieter.

Thromboembolism is a blood clot that moves through the blood stream before blocking an artery. "Despite these advances, its axial pump seems to be associated with a higher risk for clot formation, which then might cause device malfunction and peripheral thromboembolism," Rothenburger says.

"Our study shows that this serious complication can be treated effectively with intravenous administration of rt-PA. Exchange of the device, in most cases, is not necessary," he says.

The researchers followed 22 patients, 20 men and two women, with the MicroMed DeBakey VAD, finding that the pump flow was critically reduced in eight patients. In seven cases, the pump worked harder, which indicates clot formation inside the device. In one case, the demand on the pump was very low, indicating that a clot was in the opening of the device.

No emergency surgical device exchange was necessary after receiving rt-PA. No severe bleeding complications occurred, which can be a side effect of thrombolytic therapy. Four patients did have nose bleeds for three days. All patients were discharged from intensive care immediately after discontinuing rt-PA. Six patients went on to successful heart transplantation and two died on LVAD support because of multiorgan failure.

"Thrombolytic therapy with rt-PA is an effective and easily applicable treatment for clot formation inside the MicroMed DeBakey VAD," says Rothenburger.

Other co-authors are D. Hammel, M.D.; C. Schmidt, M.D.; T.D.T. Tjan, M.D.; D. Bocker, M.D.; H.H. Scheld, M.D.; and C. Schmid, M.D.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Clot-Buster Keeps Heart Devices Humming." ScienceDaily. ScienceDaily, 17 September 2002. <www.sciencedaily.com/releases/2002/09/020917071959.htm>.
American Heart Association. (2002, September 17). Clot-Buster Keeps Heart Devices Humming. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2002/09/020917071959.htm
American Heart Association. "Clot-Buster Keeps Heart Devices Humming." ScienceDaily. www.sciencedaily.com/releases/2002/09/020917071959.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins